Chapter/Section Purchase

Leave This Empty:

DNA Repair Drugs Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 DNA Repair Drugs Product Introduction
1.2 Market by Type
1.2.1 Global DNA Repair Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 Market by Application
1.3.1 Global DNA Repair Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncological
1.3.3 Stroke
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global DNA Repair Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global DNA Repair Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global DNA Repair Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global DNA Repair Drugs Sales by Region
2.4.1 Global DNA Repair Drugs Sales by Region (2017-2022)
2.4.2 Global Sales DNA Repair Drugs by Region (2023-2028)
2.5 Global DNA Repair Drugs Revenue by Region
2.5.1 Global DNA Repair Drugs Revenue by Region (2017-2022)
2.5.2 Global DNA Repair Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global DNA Repair Drugs Sales by Manufacturers
3.1.1 Global Top DNA Repair Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global DNA Repair Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DNA Repair Drugs in 2021
3.2 Global DNA Repair Drugs Revenue by Manufacturers
3.2.1 Global DNA Repair Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by DNA Repair Drugs Revenue in 2021
3.3 Global DNA Repair Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global DNA Repair Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global DNA Repair Drugs Sales by Type
4.1.1 Global DNA Repair Drugs Historical Sales by Type (2017-2022)
4.1.2 Global DNA Repair Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global DNA Repair Drugs Sales Market Share by Type (2017-2028)
4.2 Global DNA Repair Drugs Revenue by Type
4.2.1 Global DNA Repair Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global DNA Repair Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global DNA Repair Drugs Revenue Market Share by Type (2017-2028)
4.3 Global DNA Repair Drugs Price by Type
4.3.1 Global DNA Repair Drugs Price by Type (2017-2022)
4.3.2 Global DNA Repair Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global DNA Repair Drugs Sales by Application
5.1.1 Global DNA Repair Drugs Historical Sales by Application (2017-2022)
5.1.2 Global DNA Repair Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global DNA Repair Drugs Sales Market Share by Application (2017-2028)
5.2 Global DNA Repair Drugs Revenue by Application
5.2.1 Global DNA Repair Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global DNA Repair Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global DNA Repair Drugs Revenue Market Share by Application (2017-2028)
5.3 Global DNA Repair Drugs Price by Application
5.3.1 Global DNA Repair Drugs Price by Application (2017-2022)
5.3.2 Global DNA Repair Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America DNA Repair Drugs Market Size by Type
6.1.1 North America DNA Repair Drugs Sales by Type (2017-2028)
6.1.2 North America DNA Repair Drugs Revenue by Type (2017-2028)
6.2 North America DNA Repair Drugs Market Size by Application
6.2.1 North America DNA Repair Drugs Sales by Application (2017-2028)
6.2.2 North America DNA Repair Drugs Revenue by Application (2017-2028)
6.3 North America DNA Repair Drugs Market Size by Country
6.3.1 North America DNA Repair Drugs Sales by Country (2017-2028)
6.3.2 North America DNA Repair Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe DNA Repair Drugs Market Size by Type
7.1.1 Europe DNA Repair Drugs Sales by Type (2017-2028)
7.1.2 Europe DNA Repair Drugs Revenue by Type (2017-2028)
7.2 Europe DNA Repair Drugs Market Size by Application
7.2.1 Europe DNA Repair Drugs Sales by Application (2017-2028)
7.2.2 Europe DNA Repair Drugs Revenue by Application (2017-2028)
7.3 Europe DNA Repair Drugs Market Size by Country
7.3.1 Europe DNA Repair Drugs Sales by Country (2017-2028)
7.3.2 Europe DNA Repair Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific DNA Repair Drugs Market Size by Type
8.1.1 Asia Pacific DNA Repair Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific DNA Repair Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific DNA Repair Drugs Market Size by Application
8.2.1 Asia Pacific DNA Repair Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific DNA Repair Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific DNA Repair Drugs Market Size by Region
8.3.1 Asia Pacific DNA Repair Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific DNA Repair Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America DNA Repair Drugs Market Size by Type
9.1.1 Latin America DNA Repair Drugs Sales by Type (2017-2028)
9.1.2 Latin America DNA Repair Drugs Revenue by Type (2017-2028)
9.2 Latin America DNA Repair Drugs Market Size by Application
9.2.1 Latin America DNA Repair Drugs Sales by Application (2017-2028)
9.2.2 Latin America DNA Repair Drugs Revenue by Application (2017-2028)
9.3 Latin America DNA Repair Drugs Market Size by Country
9.3.1 Latin America DNA Repair Drugs Sales by Country (2017-2028)
9.3.2 Latin America DNA Repair Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa DNA Repair Drugs Market Size by Type
10.1.1 Middle East and Africa DNA Repair Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa DNA Repair Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa DNA Repair Drugs Market Size by Application
10.2.1 Middle East and Africa DNA Repair Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa DNA Repair Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa DNA Repair Drugs Market Size by Country
10.3.1 Middle East and Africa DNA Repair Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa DNA Repair Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 4SC AG
11.1.1 4SC AG Corporation Information
11.1.2 4SC AG Overview
11.1.3 4SC AG DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 4SC AG DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 4SC AG Recent Developments
11.2 ARCAGY/ GINECO GROUP
11.2.1 ARCAGY/ GINECO GROUP Corporation Information
11.2.2 ARCAGY/ GINECO GROUP Overview
11.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ARCAGY/ GINECO GROUP Recent Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Corporation Information
11.3.2 Bristol Myers Squibb Overview
11.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol Myers Squibb DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol Myers Squibb Recent Developments
11.4 British Columbia Cancer Agency
11.4.1 British Columbia Cancer Agency Corporation Information
11.4.2 British Columbia Cancer Agency Overview
11.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 British Columbia Cancer Agency DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 British Columbia Cancer Agency Recent Developments
11.5 Cambridge University Hospitals NHS Foundation Trust
11.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
11.5.2 Cambridge University Hospitals NHS Foundation Trust Overview
11.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
11.6 Genentech
11.6.1 Genentech Corporation Information
11.6.2 Genentech Overview
11.6.3 Genentech DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Genentech DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Genentech Recent Developments
11.7 Georgetown University
11.7.1 Georgetown University Corporation Information
11.7.2 Georgetown University Overview
11.7.3 Georgetown University DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Georgetown University DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Georgetown University Recent Developments
11.8 German Breast Group
11.8.1 German Breast Group Corporation Information
11.8.2 German Breast Group Overview
11.8.3 German Breast Group DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 German Breast Group DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 German Breast Group Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Overview
11.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline Recent Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Corporation Information
11.10.2 Jiangsu Hengrui Medicine Overview
11.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu Hengrui Medicine Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Corporation Information
11.11.2 Johnson & Johnson Overview
11.11.3 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Johnson & Johnson DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Johnson & Johnson Recent Developments
11.12 Jonsson Comprehensive Cancer Center
11.12.1 Jonsson Comprehensive Cancer Center Corporation Information
11.12.2 Jonsson Comprehensive Cancer Center Overview
11.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jonsson Comprehensive Cancer Center Recent Developments
11.13 Karyopharm Therapeutics
11.13.1 Karyopharm Therapeutics Corporation Information
11.13.2 Karyopharm Therapeutics Overview
11.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Karyopharm Therapeutics DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Karyopharm Therapeutics Recent Developments
11.14 KuDOS Pharmaceuticals
11.14.1 KuDOS Pharmaceuticals Corporation Information
11.14.2 KuDOS Pharmaceuticals Overview
11.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 KuDOS Pharmaceuticals Recent Developments
11.15 National Health Service
11.15.1 National Health Service Corporation Information
11.15.2 National Health Service Overview
11.15.3 National Health Service DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 National Health Service DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 National Health Service Recent Developments
11.16 National Institutes of Health
11.16.1 National Institutes of Health Corporation Information
11.16.2 National Institutes of Health Overview
11.16.3 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 National Institutes of Health DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 National Institutes of Health Recent Developments
11.17 Tesaro
11.17.1 Tesaro Corporation Information
11.17.2 Tesaro Overview
11.17.3 Tesaro DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Tesaro DNA Repair Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Tesaro Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 DNA Repair Drugs Industry Chain Analysis
12.2 DNA Repair Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 DNA Repair Drugs Production Mode & Process
12.4 DNA Repair Drugs Sales and Marketing
12.4.1 DNA Repair Drugs Sales Channels
12.4.2 DNA Repair Drugs Distributors
12.5 DNA Repair Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 DNA Repair Drugs Industry Trends
13.2 DNA Repair Drugs Market Drivers
13.3 DNA Repair Drugs Market Challenges
13.4 DNA Repair Drugs Market Restraints
14 Key Findings in The Global DNA Repair Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer